BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 24139209)

  • 1. Characteristic tumor growth patterns as novel histomorphologic predictors for lymph node metastasis in papillary thyroid carcinoma.
    Jung YY; Lee CH; Park SY; Park HJ; Min HS; Won JK; Kim BS; Ryu HS
    Hum Pathol; 2013 Dec; 44(12):2620-7. PubMed ID: 24139209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.
    Paulson L; Shindo M; Schuff K; Corless C
    Arch Otolaryngol Head Neck Surg; 2012 Jan; 138(1):44-9. PubMed ID: 22249628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomorphological factors and BRAF mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma.
    Chung SY; Lee JS; Lee H; Park SH; Kim SJ; Ryu HS
    Acta Cytol; 2013; 57(3):252-8. PubMed ID: 23636013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathological factors in risk prediction of lymph node metastasis in papillary thyroid carcinoma].
    Yue C; Zhang Y; Xing L; Zhao Y; Chen J; Jin Y; Liu H
    Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(46):3637-41. PubMed ID: 25622954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer.
    Howell GM; Nikiforova MN; Carty SE; Armstrong MJ; Hodak SP; Stang MT; McCoy KL; Nikiforov YE; Yip L
    Ann Surg Oncol; 2013 Jan; 20(1):47-52. PubMed ID: 22941165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.
    Fugazzola L; Puxeddu E; Avenia N; Romei C; Cirello V; Cavaliere A; Faviana P; Mannavola D; Moretti S; Rossi S; Sculli M; Bottici V; Beck-Peccoz P; Pacini F; Pinchera A; Santeusanio F; Elisei R
    Endocr Relat Cancer; 2006 Jun; 13(2):455-64. PubMed ID: 16728573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-Time PCR Cycle Threshold Values for the BRAFV600E Mutation in Papillary Thyroid Microcarcinoma May Be Associated With Central Lymph Node Metastasis: A Retrospective Study.
    Park VY; Kim EK; Lee HS; Moon HJ; Yoon JH; Kwak JY
    Medicine (Baltimore); 2015 Jul; 94(28):e1149. PubMed ID: 26181555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAF V600E mutation and p27 kip1 expression in papillary carcinomas of the thyroid Rodolico V; Cabibi D; Pizzolanti G; Richiusa P; Gebbia N; Martorana A; Russo A; Amato MC; Galluzzo A; Giordano C
    Cancer; 2007 Sep; 110(6):1218-26. PubMed ID: 17685465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections.
    So YK; Son YI; Hong SD; Seo MY; Baek CH; Jeong HS; Chung MK
    Surgery; 2010 Sep; 148(3):526-31. PubMed ID: 20189620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lateral cervical lymph node metastases from papillary thyroid carcinoma: predictive factors of nodal metastasis.
    Lim YS; Lee JC; Lee YS; Lee BJ; Wang SG; Son SM; Kim IJ
    Surgery; 2011 Jul; 150(1):116-21. PubMed ID: 21507446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.
    Lin KL; Wang OC; Zhang XH; Dai XX; Hu XQ; Qu JM
    Ann Surg Oncol; 2010 Dec; 17(12):3294-300. PubMed ID: 20953721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma.
    Karatzas T; Vasileiadis I; Kapetanakis S; Karakostas E; Chrousos G; Kouraklis G
    Am J Surg; 2013 Oct; 206(4):586-93. PubMed ID: 23790258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of tumor size on subclinical central lymph node metastasis in papillary thyroid microcarcinoma depends on age.
    Kim JY; Jung EJ; Park T; Jeong SH; Jeong CY; Ju YT; Lee YJ; Hong SC; Choi SK; Ha WS
    World J Surg Oncol; 2015 Feb; 13():88. PubMed ID: 25886181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node management in clinically node-negative patients with papillary thyroid carcinoma.
    Vergez S; Sarini J; Percodani J; Serrano E; Caron P
    Eur J Surg Oncol; 2010 Aug; 36(8):777-82. PubMed ID: 20584589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Factors of Lateral Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.
    Zhao W; Chen S; Hou X; Liao Q; Chen G; Zhao Y
    Pathol Oncol Res; 2019 Jul; 25(3):1245-1251. PubMed ID: 30361912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multifocal papillary thyroid carcinoma: clinical analysis of 168 cases].
    Lin YK; Sheng JM; Zhao WH; Wang WB; Yu XF; Teng LS; Ma ZM
    Zhonghua Wai Ke Za Zhi; 2009 Mar; 47(6):450-3. PubMed ID: 19595234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.
    Byeon HK; Ban MJ; Lee JM; Ha JG; Kim ES; Koh YW; Choi EC
    Ann Surg Oncol; 2012 Dec; 19(13):4259-61. PubMed ID: 23070784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encapsulation status of papillary thyroid microcarcinomas is associated with the risk of lymph node metastases and tumor multifocality.
    Cupisti K; Lehwald N; Anlauf M; Riemer J; Werner TA; Krieg A; Witte J; Chanab A; Baldus SE; Krausch M; Raffel A; Herdter C; Schott M; Knoefel WT
    Horm Metab Res; 2014 Feb; 46(2):138-44. PubMed ID: 24356791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation.
    Yip L; Nikiforova MN; Carty SE; Yim JH; Stang MT; Tublin MJ; Lebeau SO; Hodak SP; Ogilvie JB; Nikiforov YE
    Surgery; 2009 Dec; 146(6):1215-23. PubMed ID: 19958951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma.
    Buitrago D; Keutgen XM; Crowley M; Filicori F; Aldailami H; Hoda R; Liu YF; Hoda RS; Scognamiglio T; Jin M; Fahey TJ; Zarnegar R
    Ann Surg Oncol; 2012 Mar; 19(3):973-80. PubMed ID: 21879273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.